Iterum Therapeutics PLC (NASDAQ:ITRM) Director Patrick J. Heron bought 456,099 shares of the company’s stock in a transaction dated Wednesday, May 30th. The stock was bought at an average cost of $13.00 per share, with a total value of $5,929,287.00. The purchase was disclosed in a document filed with the SEC, which is available through the SEC website.

Iterum Therapeutics opened at $11.44 on Friday, MarketBeat.com reports. Iterum Therapeutics PLC has a 12 month low of $11.23 and a 12 month high of $13.00.

About Iterum Therapeutics

There is no company description available for Iterum Therapeutics PLC.

Receive News & Ratings for Iterum Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Iterum Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.